Congress 115 - HR 4733 - Opioids and STOP Pain Initiative Act

Sponsor

Cosponsors

Topics

Charitable contributions Congressional oversight Department of Health and Human Services Drug therapy Drug trafficking and controlled substances Health Health information and medical records Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Income tax credits Medical research National Institutes of Health (NIH) Prescription drugs Research administration and funding Research and development Social work, volunteer service, charitable organizations User charges and fees

Full Text

View Full Bill Text

Votes

Summary

Opioids and STOP Pain Initiative Act

This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including:

understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016;
improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and
supporting the Federal Pain Research Strategy.

NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.

Actions

Jan 3, 2018

Referred to the Subcommittee on Health.
Dec 22, 2017

Referred to the Subcommittee on Health.
Dec 21, 2017

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 21, 2017

Introduced in House

Amendments

Related Bills